Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

Int J Mol Sci. 2023 Feb 3;24(3):2991. doi: 10.3390/ijms24032991.

Abstract

Probiotics interfere with pathogenic microorganisms or reinstate the natural microbiome. Streptococcus mutans and Candida albicans are well-known emerging pathogenic bacteria/fungi for dental caries. In this study, three probiotic Lactobacilli strains (Lactobacillus plantarum 8014, L. plantarum 14917, and Lactobacillus salivarius 11741) were tested on S. mutans and C. albicans clinical isolates using a multispecies biofilm model simulating clinical cariogenic conditions. The ten pairs of clinical isolates of S. mutans and C. albicans were obtained from children with severe early childhood caries. Our study findings show a remarkable inhibitory effect of L. plantarum 14917 on S. mutans and C. albicans clinical isolates, resulting in significantly reduced growth of S. mutans and C. albicans, a compromised biofilm structure with a significantly smaller microbial and extracellular matrix and a less virulent microcolony structure. FurTre, plantaricin, an antimicrobial peptide produced by L. plantarum, inhibited the growth of S. mutans and C. albicans. The mechanistic assessment indicated that L. plantarum 14917 had a positive inhibitory impact on the expression of S. mutans and C. albicans virulence genes and virulent structure, such as C. albicans hypha formation. Future utilization of L. plantarum 14917 and/or its antimicrobial peptide plantaricin could lead to a new paradigm shift in dental caries prevention.

Keywords: Candida albicans; Lactobacillus plantarum; Streptococcus mutans; multispecies biofilm; probiotics.

MeSH terms

  • Antimicrobial Peptides
  • Biofilms
  • Candida albicans
  • Child
  • Child, Preschool
  • Dental Caries Susceptibility
  • Dental Caries* / prevention & control
  • Humans
  • Lactobacillus plantarum* / metabolism
  • Probiotics* / pharmacology
  • Probiotics* / therapeutic use
  • Streptococcus mutans

Substances

  • Antimicrobial Peptides